|
|
 |
|
Viewing report
|
|
|
|
Strategic Analysis of World DNA Microarray Markets
Frost & Sullivan, March 2004
Standardization of Products Necessary to Drive Acceptance of Microarrays as Diagnostic Tools
Manufacturers of DNA microarrays are seriously challenged to overcome laboratory-to-laboratory and platform-to-platform inconsistencies. Result variability can be linked to a variety of reasons including varying probe length and labeling protocols. Manufacturers are spending considerable time and effort in comparing their products with 'industry standards' that include quantitative polymerase chain reaction and other microarray platforms. Standardization of data is expected to be an essential part of microarrays becoming effective diagnostic tools.
This research examines the World DNA Microarray Markets and discusses the competitive factors in them. It segments the market into commercial, self-printed, and software products, and breaks down total revenues by the three major geographic locations - United States, Europe, and Rest-of-World. Industry challenges, strategies, market trends and opportunities are described in detail, and have been derived through extensive interviews with market participants.
Gene Expression Analyses Being Increasingly Used for Clinical Trials
Gene expression products are quickly becoming integral tools for both pre-clinical and clinical research. Gene expression analysis provides a snapshot of what is happening in a system at the molecular level, states the analyst. This information is vital to understand the workings of the system and the factors that change the system.
The utility of microarray technology in the diagnostics arena is beginning to be explored. In diagnostics, microarray technology is expected to be crucial for making decisions relating to therapeutics. Microarrays have been used in research for almost a decade; however, it is their promise as a therapeutic tool that is expected to drive the market.
Commercial Products to Drive Market Growth
World DNA microarray revenue was $596 million in 2003 and is expected to reach $937 million by 2010, at a compound annual growth rate of 6.7 percent. Market growth is expected to be derived from the substantial gains in the commercial market and continued growth in the scanner market.
Customers who bought this item also bought
Microarray Markets
U.S. DNA Microarray Markets
Beyond Expression Arrays: Emerging Applications for Genomic Microarray Technology
World Protein Arrays Markets
DNA Sequencing 2008
The Market For DNA Microarrays: Core Lab & End-User Perspectives
Protein Microarrays: Technology Adoption & Utilization
Protein Arrays: Commercial Opportunities, Legal Trends, and Technology Analyses
Emerging Technologies in Lab-on-a-Chip: Microarrays and Biochips (Technical Insights)
Strategic Analysis of the South Korea Commercial Vehicles Market
Analyzing Microarray Gene Expression Data
Statistics for Microarrays: Design, Analysis and Inference
|
|
|
|
